Table 1.

Hypotheses.

Hypothesis 1	Women who have had longer relationships with their PCPs/WHPs are more likely to have had a discussion about BC risk with one of those providers.
Hypothesis 2	Women who have had longer relationships with their PCPs/WHPs are more likely to have seen a specialist about their BC risk.
Hypothesis 3	Women who have discussed BC risk with a PCP/WHP are more likely to have seen a specialist about their BC risk.
Hypothesis 4	Better access to HCP-related facilitators is associated with more risk-management behavior Women who have discussed BC risk with a PCP/WHP are more likely to be (a) concordant with BC screening guidelines for high-risk women and (b) aware of risk-reduction options. Women with longer PCP/WHP relationships are more likely to be (c) concordant with BC screening guidelines for high-risk women and (d) aware of risk-reduction options. Women with who have seen a specialist about their BC risk are more likely to be (e) concordant with BC screening guidelines for high-risk women and (f) aware of risk-reduction options.
Hypothesis 5	Black women have worse access to HCP-related facilitators: (5a) having a conversation about BC risk with a PCP/WHP, (5b) having longer-term relationships with PCPs/WHPs, (5c) seeing a specialist about BC risk.
Hypothesis 6	Black women exhibit less risk-management behavior, specifically: (6a) guideline-concordant screening, and (6b) awareness of risk- reduction options.
Hypothesis 7	Women who are aware that they have a BRCA mutation have better access to HCP-related facilitators: (7a) having a conversation about BC risk with a PCP/WHP, (7b) having longer-term relationships with PCPs/WHPs, (7c) seeing a specialist about BC risk.
Hypothesis 8	Women who are aware that they have a BRCA mutation engage in more risk-management behavior, specifically: (8a) guideline-concordant screening, and (8b) awareness of risk-reduction options.